K+-CHANNEL BLOCKERS AND CORONARY VASOCONSTRICTION IN GUINEA-PIG PERFUSED HEARTS IN-VITRO

被引:4
作者
GWILT, M
ORME, J
ROURKE, JD
HENDERSON, CG
机构
[1] Cardiovascular Department, Zeneca Pharmaceuticals, Macclesfield, Cheshire, SK10 4TG, Alderley Park
关键词
D O I
10.1111/j.2042-7158.1993.tb05677.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Glibenclamide, glipizide and phentolamine, three drugs which have been reported to block ATP-dependent potassium channels, increased the coronary perfusion pressure in guinea-pig isolated hearts perfused at constant flow. Blockers of other types of potassium channels, 4-aminopyridine and UK-66,914, did not significantly increase perfusion pressure. Exposing hearts to a single concentration of 3 muM glibenclamide caused a greater degree of vasoconstriction than when this was preceded by lower concentrations. The 3 muM glibenclamide-induced vasoconstriction was reduced by prazosin (1 muM), mepyramine (0.1 muM) and ranitidine (10 mum) but not by a combination of mepyramine and ranitidine or by ritanserin (0.01 muM). These results suggest that a component of the vasoconstriction induced by glibenclamide may result indirectly from the release of vasoactive mediators.
引用
收藏
页码:671 / 674
页数:4
相关论文
共 24 条
[1]   ROLE OF H1-RECEPTORS AND H2-RECEPTORS IN CORONARY VASCULAR-RESPONSE TO HISTAMINE OF ISOLATED PERFUSED HEARTS OF GUINEA-PIGS AND RABBITS [J].
BROADLEY, KJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1975, 54 (04) :511-521
[2]  
BURNSTOCK G, 1988, BRIT J PHARMACOL, V8, pS95
[3]   HYPOXIC DILATION OF CORONARY-ARTERIES IS MEDIATED BY ATP-SENSITIVE POTASSIUM CHANNELS [J].
DAUT, J ;
MAIERRUDOLPH, W ;
VONBECKERATH, N ;
MEHRKE, G ;
GUNTHER, K ;
GOEDELMEINEN, L .
SCIENCE, 1990, 247 (4948) :1341-1344
[4]  
FOSSET M, 1988, J BIOL CHEM, V263, P7933
[5]   THE AMINOPYRIDINES [J].
GLOVER, WE .
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1982, 13 (04) :259-285
[6]   RELEASE OF HISTAMINE BY SYMPATHETIC-NERVE STIMULATION IN THE GUINEA-PIG HEART AND MODULATION OF ADRENERGIC RESPONSES - A PHYSIOLOGICAL-ROLE FOR CARDIAC HISTAMINE [J].
GROSS, SS ;
GUO, ZG ;
LEVI, R ;
BAILEY, WH ;
CHENOUDA, AA .
CIRCULATION RESEARCH, 1984, 54 (05) :516-526
[7]   PHARMACOLOGICAL PROFILE OF CROMAKALIM IN THE TREATMENT OF MYOCARDIAL-ISCHEMIA IN ISOLATED RAT HEARTS AND ANESTHETIZED DOGS [J].
GROVER, GJ ;
SLEPH, PG ;
DZWONCZYK, S .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 16 (06) :853-864
[8]  
GWILT M, 1992, EUR J PHARMACOL, V220, P231
[9]   ELECTROPHYSIOLOGIC PROPERTIES OF UK-66,914, A NOVEL CLASS-III ANTIARRHYTHMIC AGENT [J].
GWILT, M ;
DALRYMPLE, HW ;
BURGES, RA ;
BLACKBURN, KJ ;
DICKINSON, RP ;
CROSS, PE ;
HIGGINS, AJ .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 (03) :376-385
[10]  
HAASS M, 1991, N-S ARCH PHARMACOL, V344, P527